𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of risperidone in the treatment of delirium in elderly patients

✍ Scribed by Koji IKEZAWA; Leonides CANUET; Ryouhei ISHII; Masao IWASE; Yoshio TESHIMA; Masatoshi TAKEDA


Book ID
109059018
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
84 KB
Volume
8
Category
Article
ISSN
1346-3500

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Risperidone versus olanzapine for the tr
✍ Sung-Wan Kim; Joon-An Yoo; Sam-Yeon Lee; Seon-Young Kim; Kyung-Yeol Bae; Su-Jin πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

## Abstract ## Objective This study compared the effectiveness of risperidone and olanzapine in the treatment of delirium. ## Methods This was a 7‐day, randomized, comparative clinical trial of risperidone and olanzapine in patients with delirium. The primary outcome measure was the Delirium Rat

Long-term safety and efficacy of long-ac
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (β‰₯65 years) with psychosis stabilized on oral or depot a

Efficacy and safety of long-acting rispe
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; MariΓ«lle Eerd πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi